Jump to content

Immunize Europe Forum

  • Content count

  • Joined

  • Last visited

Community Reputation

0 Neutral

About Immunize Europe Forum

  • Rank
    Advanced Member

Personal Information

  • Gender
  1. Social Media Consultancy

    WHO social media project: exploratory phase Background Social media is playing an increasingly significant role in information dissemination and in the formation and expression of public opinion and concerns related to immunization and thus have the power to both damage and support immunization programmes. National immunization programmes would like to explore the opportunities and potential pitfalls of actively engaging in social media, including the options to optimize the considerable potential of this effort and the resources and best practice process steps needed for this work. Monitoring of social media is another activity offering potentially a rich source of information that may guide programme planning. Lastly, with anti-vaccination voices being vocal in many Member States and effectively using social media in their effort to gain influence on people’s vaccination decisions, immunization programme managers are seeking ways to counteract this, if at all possible. See attached notice. Concept note(1).pdf
  2. Containment is forever!

    The hard work on containment is already underway and to find out more about how such a prolific virus will be rounded up and stored safely, read this interview with WHO scientist Dr Eugene Gavrilin. http://www.euro.who.int/en/health-topics/communicable-diseases/poliomyelitis/news/news/2017/10/15th-anniversary-of-polio-free-certification-in-the-european-region-but-the-hard-work-to-prevent-future-cases-is-not-over/a-place-for-polio-containment-is-forever
  3. WHO’s Vaccine Safety Net (VSN) project is calling for volunteers to assist the VSN secretariat in reviewing candidate websites against criteria for good information practices as defined by the Global Advisory Committee on Vaccine Safety (GACVS). Qualifications Qualified candidates will be students, academics or professionals in a related field, such as medicine, immunology, or virology , with native language skills in the language of a candidate website. Languages of particular interest include but are not limited to: Arabic, Bulgarian, Chinese, Czech, Dutch, Farsi, German, Hungarian, Italian, Japanese, Polish, Portuguese, Spanish, Swedish, Thai and Turkish. Review process Interested candidates will be placed on a roster of reviewers and asked to review a website in the relevant language as the need arises. The reviewing task will be based on a detailed reviewers’ guide and is expected to take approximately 3 hours per website. The reviewer will report his or her findings and recommendations to the VSN secretariat, which will then decide whether to invite the website to become a member of the network or suggest required changes as a prerequisite for joining. Benefits for the reviewer As token of appreciation, each reviewer will receive a letter of appreciation from the VSN coordinator, acknowledging his or her contribution to this WHO project. About VSN Due to the success of immunization worldwide, several vaccine-preventable diseases have been contained and are no longer perceived by many as a threat. However, certain groups have questioned the utility of vaccines in spite of their proven success in controlling diseases. Moreover, a number of websites have been established providing misleading and alarming vaccine-safety information, causing undue fears, particularly among parents. The Vaccine Safety Net (VSN) was established in 2003 by the World Health Organization, following the request from governments, non-governmental organizations and UNICEF to promote balanced and science-based information about vaccine safety. VSN is continually evolving and currently comprises member-websites from 30 countries providing information in 15 different languages. The websites are run by governmental agencies, grassroots organizations, academic institutions, professional organizations, private non-profit entities as well as specific information repositories/platforms. VSN aims to facilitate easy access to reliable, understandable, evidence-based information on the safety of vaccines for internet users, regardless of their geographic location and language and to foster international collaboration among stakeholders to: increase awareness about vaccines, reduce vaccine hesitancy and strengthen confidence in vaccines by seeking to better understand internet users’ needs, behaviours and preferences; provide reliable information tailored to users’ needs; and communicate vaccine safety information through a diversity of digital channels. If you are interested in volunteering your time to this important project, please send your CV and contact details to: gvsi(at)who.int
  4. Robb Butler, WHO, on HPV vaccine

  5. Press release Copenhagen, 26 September 2017 In the WHO European Region, 42 of 53 countries have interrupted endemic transmission of measles, and 37 countries have interrupted endemic transmission of rubella as of the end of 2016. This was determined by the European Regional Verification Commission for Measles and Rubella Elimination (RVC) at its 6th meeting in June 2017. Full press release
  6. This position paper replaces the 2006 WHO position paper on diphtheria vaccine. It incorporates recent evidence on diphtheria and provides revised recommendations on the optimal number of doses and timing of diphtheria vaccination. In view of the widespread use of combination vaccines, it provides guidance on the alignment of vaccination schedules for different antigens included in routine childhood immunization programmes. http://www.who.int/immunization/policy/position_papers/wer_31_diphtheria_updated_position_paper.pdf?ua=1
  7. WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) for 2016 are now available on the WHO website: http://www.who.int/immunization/monitoring_surveillance/data/en/
  8. Special issue of Journal of Infectious Diseases on “Polio Endgame & Legacy-Implementation, Best Practices, and Lessons Learned” See also article: Acceptance of the Administration of Multiple Injectable Vaccines in a Single Immunization Visit in Albania
  9. WHO Hepatitis B position paper (July 2017): http://apps.who.int/iris/bitstream/10665/255841/1/WER9227.pdf?ua=1 (PDF) See all Hepatitis B position papers: http://www.who.int/immunization/policy/position_papers/hepatitis_b/en/
  10. WHO page with information and resources on the World Hepatitis Day, 28 July 2017. http://www.who.int/campaigns/hepatitis-day/2017/en/
  11. Vaccination and trust library (WHO)

    WHO: Vaccination and trust (2017) This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines and vaccination, both in ongoing work and during crises. The evidence draws on a vast reserve of laboratory research and fieldwork within psychology and communication. It examines how people make decisions about vaccination; why some people are hesitant about vaccination; and the factors that drive a crisis, covering how building trust, listening to and understanding people, building relations, communicating risk and shaping messages to the audiences may mitigate crises. This background document is part of the Vaccination and trust library, which includes a series of support documents with practical guidance for specific situations.
  12. **** For wide dissemination **** The Global Influenza Programme (GIP) in WHO HQ Geneva seeks to recruit a consultant for the development of comprehensive communications strategies and supporting materials for several areas of work currently underway. Expected start date is 1 July 2017. Contract duration is 5 months, homebased, with visits to Geneva. Below is a brief description of the work to be performed: Activities for the Pandemic Influenza Severity Assessment Tool (PISA) Develop a comprehensive communications strategy, a strategy for rollout, and a method for evaluating and refining the strategy Develop a training package for communications officers (at both the global and national level) Develop a website devoted to PISA Activities for burden of disease (BoD) Develop a comprehensive communications strategy, a strategy for rollout, and a method for evaluating and refining the strategy Develop a training package for communications officers Develop a website devoted to BoD Activities for global influenza situation reporting Develop a comprehensive communications strategy, a strategy for rollout, and a method for evaluating and refining the strategy Activities for risk assessment tools Develop, in consultation with WHO staff and experts, a comprehensive document explaining the currently available risk assessment tools, which tool is appropriate given a certain situation, identification of target groups, and tailored messages to various audiences. Please see the attached terms of reference for more details on the activities and the expected qualifications. Interested service providers should submit the following documents to WHOinfluenza@who.int by 15 June 2017, 23.59h (Geneva time): CV (for individual contractors) or Company Profile (for institutional applications) Expression of interest (cover letter) that includes a financial proposal as detailed in the terms of reference. Best regards, Global Influenza Programme World Health Organization Geneva, Switzerland Attachment: Terms of Reference_APW_PISA_communications_1_June_2017.pdf
  13. The Vaccine-preventable Diseases and Immunization programme (VPI) of the WHO Regional Office for Europe is looking for a qualified expert in vaccine safety to compliment its team of immunization professionals. Deadline for applications is 24 June 2017. For more information see: UN JOBS website.
  14. Wiser Immuniser Online Course - Cohort 6

    The ESPID Wiser Immunisers online course has been created in collaboration with the World Health Organization and is aimed at any health professional involved with vaccination, in particular general practitioners, paediatricians and clinical trainees with an interest or specialty in paediatrics and/or infectious diseases. Cohort 4, the registration opens on 14th August 2017, the course begins on 16th October 2017 Cohort 5, the registration opens on 5th February 2018, the course begins on 9th April 2018 Cohort 6, the registration open on 13th August 2018, the course begins on 15th October 2018. Go to the course page